Ganglioneuroblastoma - 7 Studies Found
| Completed |
: Phase II Study of Proton Radiation Therapy for Neuroblastoma :
: 2014-04-10 : Radiation: Proton Beam Radiation Therapy Proton radiation will be delivered daily for 3-4 weeks, dependi |
| Recruiting |
: Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma :
: 2013-01-09 :
|
| Not yet recruiting |
: Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma :
: |
| Recruiting |
: Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 :
: 2014-12-04 :
|
| Recruiting |
: Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma :
: |
| Recruiting |
: Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma :
: |
| Completed |
: Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin :
: |